Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA3 | P07451 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
| ▸ | CA6 | P23280 | 1/20 | 0.49 |
| ▸ | CA5A | P35218 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15994168 | 0.81 | TSHR (0.55) | MAPK1CA1CA2GAACA12 | |
| SCHEMBL2103568 | 0.81 | MAPK1 (0.55) | MAPK1CA1CA2GAACA12 | |
| SCHEMBL7035059 | 0.79 | MAPK1 (0.53) | MAPK1CA1CA2GAAALDH1A1 | |
| SCHEMBL9631542 | 0.79 | MAPK1 (0.53) | MAPK1CA1CA2GAAALDH1A1 | |
| SCHEMBL3154682 | 0.79 | MAPK1 (0.53) | MAPK1CA1CA2GAAALDH1A1 | |
| SCHEMBL27635231 | 0.79 | MAPK1 (0.53) | MAPK1CA1CA2GAAALDH1A1 | |
| SCHEMBL7195191 | 0.79 | ALDH1A1 (0.56) | MAPK1ALDH1A1MEN1KMT2ACES1 | |
| SCHEMBL27389983 | 0.78 | CA1 (0.58) | MAPK1CA1CA2GAACA12 | |
| SCHEMBL12590141 | 0.77 | ALDH1A1 (0.57) | MAPK1CA1CA2GAACA12 | |
| SCHEMBL17018433 | 0.77 | ALDH1A1 (0.57) | MAPK1CA1CA2GAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4727818-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| CN-1206921-C | Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type | NOVO JYMEZ AS (DK) | 2005-06-22 | — | — | CN | claimed |
| EP-1128730-B1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES AS (DK) | 2003-05-02 | — | — | EP | claimed |
| JP-2002529380-A | — | — | 2002-09-10 | — | — | JP | claimed |
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2002-07-18 | — | — | US | claimed |
| CN-1325270-A | Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type | NOVO JYMEZ AS (DK) | 2001-12-05 | — | — | CN | claimed |
| EP-1128730-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | Novozymes A/S (DK) | 2001-09-05 | — | — | EP | claimed |
| WO-2000027204-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2000-05-18 | — | — | WO | claimed |
| EP-3444336-B1 | CLEANING AGENT | PROCTER & GAMBLE (US) | 2024-05-08 | — | — | EP | disclosed |
| US-20210147765-A9 | CLEANING KIT | THE PROCTER AND GAMBLE COMPANY | 2021-05-20 | — | — | US | disclosed |
| US-20210071117-A9 | CLEANING AGENT | THE PROCTER AND GAMBLE COMPANY | 2021-03-11 | — | — | US | disclosed |
| CN-110892065-A | Cleaning method | 宝洁公司 | 2020-03-17 | — | — | CN | disclosed |
| US-20200063073-A1 | METHOD OF CLEANING | THE PROCTER AND GAMBLE COMPANY | 2020-02-27 | — | — | US | disclosed |
| US-20200063071-A1 | CLEANING AGENT | PROCTER & GAMBLE (US) | 2020-02-27 | — | — | US | disclosed |
| WO-2001074980-A2 | ENZYME TABLETS FOR CLEANING IMPROVEMENT | NOVOZYMES A/S (DK) | 2001-10-11 | — | — | WO | disclosed |
| EP-1128730-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | Novozymes A/S (DK) | 2001-09-05 | — | — | EP | disclosed |
| WO-2001048304-A1 | PROCESS FOR REMOVAL OF EXCESS DISPERSE DYE FROM PRINTED OR DYED TEXTILE MATERIAL | NOVOZYMES A/S (DK) | 2001-07-05 | — | — | WO | disclosed |
| WO-2001010195-A1 | REDUCTION OF MALODOUR IN SOILED ANIMAL LITTER | NOVOZYMES A/S (DK) | 2001-02-15 | — | — | WO | disclosed |
| WO-2000068324-A2 | ENZYMATIC PRESERVATION OF WATER BASED PAINTS | NOVOZYMES A/S (DK) | 2000-11-16 | — | — | WO | disclosed |
| WO-2000027204-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | LPO, MPO, LCT | MAPK1 4012/4885CA1 1495/4885CA2 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.